<DOC>
	<DOCNO>NCT01981863</DOCNO>
	<brief_summary>It common practice use antifibrinolytic agent cardiopulmonary bypass . They without side effect . The investigator want show proof fibrinolysis standard sternotomy cardiac surgery patient cardiopulmonary bypass , antifibrinolytic agent start cardiopulmonary bypass .</brief_summary>
	<brief_title>Fibrinolysis Before Cardiopulmonary Bypass ?</brief_title>
	<detailed_description>Double-blind , placebo control , prospective study two group 20 patient . Control group ( A ) receive standard Epsilonaminocaproic acid treatment cardiopulmonary bypass ( 10 gr load dose , 1 gr/hr infusion ) , second group ( B ) receive placebo . Before start Epsilonaminocaproic acid/placebo , D-Dimers Thromboelastography measure , repeat full heparinization . After heparinization group A receive placebo , group B Epsilonaminocaproic acid .</detailed_description>
	<mesh_term>Aminocaproic Acid</mesh_term>
	<mesh_term>Antifibrinolytic Agents</mesh_term>
	<criteria>All adult patient , undergo first time sternotomy Coronary artery bypass grafting/Aortic valve replacement/aortic surgery Resternotomy , renal insufficiency , deep hypothermia , age &lt; 18 yr</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>cardiac surgery</keyword>
	<keyword>cardiopulmonary bypass</keyword>
	<keyword>fibrinolysis</keyword>
	<keyword>thromboelastography</keyword>
	<keyword>D-Dimers</keyword>
	<keyword>antifibrinolytic agent</keyword>
</DOC>